Cristina Garcia

Sobre mi

Publicacions destacades

• Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report

  Autors:

  Duss FR; Garcia de la Mària C; Croxatto A; Giulieri S; Lamoth F;

  Manuel O; Miró JM .

  Referència: Journal Of Antimicrobial Chemotherapy 2019.

• AUC/MIC Pharmacodynamic Target Is Not a Good Predictor of Vancomycin Efficacy in Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis.

  Autors:

  Castañeda X; García-de-la-Mària C; Gasch O; Pericas JM; Armero Y;

  (...)

  Soto S; Moreno A; Marco F; Miró JM; Hospital Clinic Endocarditis Study Group.

  Veure llistat complet d'autors

  Referència: Antimicrobial Agents And Chemotherapy 2017.

• Influence of Vancomycin Minimum Inhibitory Concentration on the Outcome of Methicillin-Susceptible Staphylococcus aureus Left-Sided Infective Endocarditis Treated with Anti-staphylococcal Beta-Lactam Antibiotics; a Prospective Cohort Study by the International Collaboration on Endocarditis.

  Autors:

  Pericàs JM; Messina JA; Garcia-de-la-Mària C; Park L; Sharma-Kuinkel BK;

  (...)

  Chu VH; Moreno A; Fowler VG; Miró JM; International Collaboration on Endocarditis Microbiology Investigators.

  Veure llistat complet d'autors

  Referència: Clinical Microbiology And Infection 2017.

• Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.

  Autors:

  Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J;

  (...)

  Llopis J; Marco F; Moreno A; Miró JM; Hospital Clinic Endocarditis Study Group.

  Veure llistat complet d'autors

  Referència: Journal Of Antimicrobial Chemotherapy 2017.

• Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.

  Autors:

  Garcia-de-la-Maria C; Xiong YQ; Pericas JM; Armero Y; Moreno A;

  (...)

  Tran TT; Arias CA; Sullam PM; Bayer AS; Miro JM .

  Veure llistat complet d'autors

  Referència: Antimicrobial Agents And Chemotherapy 2017.

• Fosfomycin plus beta-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus

  Autors:

  del Rio, A; Garcia-de-la-Maria, C; Entenza, JM; Gasch, O; Armero, Y;

  (...)

  Gatell, JM; Moreno, A; Moreillon, P; Marco, F; Miro, JM.

  Veure llistat complet d'autors

  Referència: Antimicrobial Agents And Chemotherapy 2016.

Projectes destacats

• Prevention of vascular catheter-related infections by the FUNctionalization of CATHeters with thermically activated hydrogels with antimicrobial agents of broad spectrum (FUNCATH).

  Investigador/a principal: Cristina Garcia de la Maria

  Finançador: Fundació La Marató de TV3

  Codi: 75/C/2018

  Durada: 15/01/2019 - 31/12/2022

• In vitro and experimental endocarditis model study of the efficacy of new oral and parenteral combinations of antibiotics for outpatient treatment of infectious endocarditis

  Investigador/a principal: José Maria Miró Meda

  Finançador: ISCIII (Participante)

  Codi: PI 20/00830

  Durada: 01/01/2021

• Staphylococcus aureus sensitivity to CF-301 Lysin in an in vitro study by Broth Microdilution Method.

  Investigador/a principal: Josep M. Miró Meda

  Finançador: ContraFect Corporation

  Durada: 01/03/2019

• Estudio de la eficacia de daptomicina asociada a otros antibióticos en el tratamiento de la endocarditis experimental por Staphylococcus aureus resistente o no a meticilina (SARM/SASM) y Staphylococcus epidermidis resistentes a meticilina (SERM) y a vancomicina (VRSE)

  Investigador/a principal: Jose Maria Miro Meda

  Finançador: Fundació Privada Clínic per a la Recerca Biomèdica (Sede o evento); Instituto de Salud Carlos III

  Durada: 01/01/2011 - 31/12/2013

• To evaluate wether the combination of gentamicin and daptomycin (at doses of 6 mg/ kg or 10 mg/Kg) prevents the development of daptomycin resistance in the treatment of experimental endocarditis in rabbits infected with a penicillin-resistant Streptococcus mitis strain that develops a high level of daptomycin resistance when daptomycin is given in monotherapy.

  Investigador/a principal: Jose Maria Miro Meda

  Finançador: Cubist Pharmaceutical ; Fundació Privada Clínic per a la Recerca Biomèdica (Participante)

  Durada: 01/01/2011